WIZE PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

On December 30, 2020, Wize Pharma, Inc. (the "Company"), entered into a Bid Implementation Agreement ("BIA") with Cosmos Capital Limited, a digital infrastructure provider based in Sydney, Australia ("Cosmos"). The BIA provides, among other things, that the Company will make an off-market takeover offer to acquire all of the outstanding shares of Cosmos, subject to satisfaction of various closing conditions set forth in the BIA, resulting in Cosmos becoming a wholly-owned subsidiary of Wize.

On December 30, 2020, the Company and Cosmos issued a joint press release announcing the BIA. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.   Description

99.1            Press Release, dated December 30, 2020: Wize Pharma and Cosmos Capital
              enter into Bid Implementation Agreement




                                       1

© Edgar Online, source Glimpses